Biomarker modeling of Alzheimer's disease

Neuron
Clifford R Jack, David M Holtzman

Abstract

Alzheimer's disease (AD) is a slowly progressing disorder in which pathophysiological abnormalities, detectable in vivo by biomarkers, precede overt clinical symptoms by many years to decades. Five AD biomarkers are sufficiently validated to have been incorporated into clinical diagnostic criteria and commonly used in therapeutic trials. Current AD biomarkers fall into two categories: biomarkers of amyloid-β plaques and of tau-related neurodegeneration. Three of the five are imaging measures and two are cerebrospinal fluid analytes. AD biomarkers do not evolve in an identical manner but rather in a sequential but temporally overlapping manner. Models of the temporal evolution of AD biomarkers can take the form of plots of biomarker severity (degree of abnormality) versus time. In this Review, we discuss several time-dependent models of AD that take into consideration varying age of onset (early versus late) and the influence of aging and co-occurring brain pathologies that commonly arise in the elderly.

References

Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Feb 20, 1987·Science·P H St George-HyslopD Drachman
May 1, 1995·Neurobiology of Aging·D W DicksonP Davies
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
May 1, 1997·Acta Neuropathologica·C DuyckaertsJ J Hauw
Jul 1, 1997·Neurobiology of Aging·W SilvermanJ Wegiel
Jun 16, 1999·Archives of Neurology·V HaroutunianR C Mohs
May 11, 2005·Neurology·N C FoxUNKNOWN AN1792(QS-21)-201 Study
Jan 13, 2006·Archives of Neurology·William R MarkesberyDavid R Wekstein
Oct 3, 2006·Brain : a Journal of Neurology·Katharina BuergerHarald Hampel
Aug 9, 2007·Annals of Neurology·Keith A JohnsonSteven M Greenberg
Mar 15, 2008·Brain : a Journal of Neurology·Milos D IkonomovicSteven T DeKosky
Apr 2, 2008·NeuroImage·Xue HuaUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Dec 2, 2008·Brain : a Journal of Neurology·E C MorminoUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 6, 2009·The Journal of Nutrition, Health & Aging·G B Frisoni, A Delacourte
Mar 14, 2009·The Journal of Biological Chemistry·Bess FrostMarc I Diamond
Apr 3, 2009·Brain : a Journal of Neurology·Clifford R JackUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Apr 21, 2009·Neuron·William W SeeleyMichael D Greicius
May 22, 2009·Journal of Neurochemistry·John Hardy
May 23, 2009·Brain : a Journal of Neurology·Rahul S DesikanUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jun 9, 2009·Nature Cell Biology·Florence ClavagueraMarkus Tolnay
Jul 23, 2009·JAMA : the Journal of the American Medical Association·Niklas MattssonKaj Blennow
Jul 29, 2009·Neurology·P VemuriUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Aug 15, 2009·Neuron·Jungsu KimDavid M Holtzman
Aug 20, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Nelleke TolboomBart N M van Berckel
Sep 11, 2009·The New England Journal of Medicine·Liang-Wei Chen
Sep 11, 2009·Annals of Neurology·Julie A SchneiderDavid A Bennett
Oct 14, 2009·Neurology·W J JagustUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jan 19, 2010·Annals of Nuclear Medicine·Alexander Drzezga

❮ Previous
Next ❯

Citations

Jul 12, 2014·Brain : a Journal of Neurology·Alexandra L YoungUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jun 14, 2014·Current Opinion in Neurology·Daniela Perani
Nov 9, 2014·Acta Neuropathologica·Clifford R Jack
Nov 25, 2014·Alzheimer's Research & Therapy·Jasmin Rahimi, Gabor G Kovacs
Sep 4, 2014·European Journal of Clinical Nutrition·C Bastin, E Salmon
Feb 6, 2016·International Journal of Molecular Sciences·Gabor G Kovacs
Feb 9, 2016·ACS Chemical Neuroscience·Jason D Ulrich, David M Holtzman
Jan 24, 2016·Human Brain Mapping·Owen R PhillipsMargherita Di Paola
Feb 2, 2016·Ageing Research Reviews·Victor L Villemagne, Gaël Chételat
Jan 20, 2016·Nature Reviews. Neurology·Clifford R JackStephanie J B Vos
Jan 28, 2016·Brain : a Journal of Neurology·Elena Rodriguez-VieitezAgneta Nordberg
Nov 14, 2015·American Journal of Hypertension·Timothy M Hughes, Kaycee M Sink
May 31, 2016·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Erik StomrudOskar Hansson
Dec 1, 2015·Neurochemistry International·Antero SalminenMikko Hiltunen
Oct 31, 2015·Annual Review of Pharmacology and Toxicology·Kelly M Haston, Steven Finkbeiner
Oct 3, 2015·Brain : a Journal of Neurology·Clifford R JackRonald C Petersen
Mar 19, 2015·Current Biology : CB·Alex C Keene, William J Joiner
Nov 22, 2015·Ageing Research Reviews·Elena RolandiEnrica Cavedo
Dec 15, 2015·Biochimica Et Biophysica Acta·Timothy M Hughes, Suzanne Craft
Jun 19, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Kristel SleegersUNKNOWN BELNEU consortium
Dec 22, 2015·Seminars in Nuclear Medicine·Laura B EisenmengerJames M Mountz
Sep 12, 2015·Medical Image Analysis·Alexandra L YoungUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 11, 2016·Brain : a Journal of Neurology·Rik OssenkoppeleGil D Rabinovici
Jun 5, 2015·Neurocase·Georges NaasanHoward J Rosen
Aug 9, 2015·Neurobiology of Disease·Eric BéliveauFrédéric Calon
Dec 3, 2014·Neuron·Diana E PankevichSteve E Hyman
Jan 27, 2015·Alzheimer's Research & Therapy·Robert Vassar
Dec 24, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Hlin KvartsbergKaj Blennow
Sep 10, 2015·Nature Neuroscience·Lan YeMathias Jucker
Jan 31, 2016·The Journal of Pharmacology and Experimental Therapeutics·Eline M T van MaanenMeindert Danhof
Dec 3, 2014·Annals of Neurology·Rik OssenkoppeleGil D Rabinovici
Sep 27, 2014·Journal of Neurochemistry·Dominique GarinCatherine Ghezzi
Aug 8, 2015·Geriatrics & Gerontology International·Yuan-Han YangChing-Kuan Liu
May 11, 2015·Acta Neuropathologica Communications·Katja HochgräfeEva-Maria Mandelkow
May 28, 2016·Annals of Clinical and Translational Neurology·Nicholas S LimAlice S Chen-Plotkin
Sep 1, 2015·Journal of Neuroscience Methods·Kenichi OtaUNKNOWN Alzheimer's Disease Neuroimaging Initiative

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.